JPM26: Boston Scientific acquires Penumbra in $14.5bn deal
Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech…
15 Jan 2026
JPM26: Intuitive’s stock falls despite positive FY25 financials
Robotic surgery giant Intuitive’s stock has fallen despite reporting positive growth in its full year 2025 (FY25) and Q4 financials. Ahead of the company’s presentation at this year’s J.P. Morgan…
14 Jan 2026
JPM26: Zimmer Biomet reveals plans for largest patient campaign in its history
Zimmer Biomet CEO Ivan Tornos has outlined plans for the largest direct to consumer (DTC) campaign in the company’s history as part of an effort to regain market share from…
14 Jan 2026
JPM26: GE HealthCare’s CEO maintains disciplined M&A strategy
GE HealthCare CEO Peter Arduini has highlighted the company’s disciplined approach to M&A in order to “fill gaps and add tuck-ins” to its portfolio, while also operating as a company…
14 Jan 2026
SSG to establish medical coatings facility in Costa Rica
Surface Solutions Group (SSG), a company specialising in functional coating technologies for medical devices, has announced its entry into Costa Rica. The business will set up a new operation focused…
14 Jan 2026
AliveCor secures FDA approval for next-generation Kardia 12L ECG System
US-based AliveCor has received US Food and Drug Administration (FDA) approval for the next generation of its KAI 12L artificial intelligence (AI), powering the Kardia 12L ECG System. This update…
13 Jan 2026
JPM26: Medtronic touts billion-dollar market opportunity for Altaviva
Medtronic CEO Geoff Martha has emphasised the strong interest levels and market potential for its Altaviva device for urge urinary incontinence (UUI) treatment. Martha spoke during a wide-ranging presentation outlining…